MicroRNA-21 (miR-21) in breast cancer: From apoptosis dysregulation to therapeutic opportunities-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

MicroRNA-21 (miR-21) in breast cancer: From apoptosis dysregulation to therapeutic opportunities

Published:2024-10 Issue: Volume:262 Page:155572
ISSN:0344-0338
Container-title:Pathology - Research and Practice
language:en
Short-container-title:Pathology - Research and Practice

Author:

Syed Rahamat Unissa,Banu Humera,Alshammrani Alia,Alshammari Maali D.,G Satheesh Kumar,Kadimpati Kishore Kumar,Khalifa Amna Abakar Suleiman,Aboshouk Nayla Ahmed Mohammed,Almarir Aisha mofareh,Hussain Arshad,Alahmed Farah Khaled

Funder

University of Hail

Publisher

Elsevier BV

Reference198 articles.

1. MicroRNAs as biomarker for breast cancer;Aggarwal;Endocr. Metab. Immune Disord. Drug Targets,2020

2. Unraveling the potential of miRNAs from CSCs as an emerging clinical tool for breast cancer diagnosis and prognosis;Nogueras Pérez;Int J. Mol. Sci.,2023

3. Breast cancer-delivered exosomal miRNA as liquid biopsy biomarkers for metastasis prediction: a focus on translational research with clinical applicability;Baldasici;Int J. Mol. Sci.,2022

4. Apoptosis and the target genes of microRNA-21;Buscaglia;Chin. J. Cancer,2011

5. MicroRNAs: new biomarkers for diagnosis, prognosis, therapy prediction and therapeutic tools for breast cancer;Bertoli;Theranostics,2015

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP